Background
Titles
- Professor of Psychiatry and Behavioral Sciences
New masking guidelines are in effect starting April 24.
Vaccines & Boosters | Testing | Visitor Guidelines | Coronavirus
Kelly Elaine Dunn, Ph.D., M.B.A., M.S.
Opioid treatment; Incentive-based treatments; Cigarette smoking; Alcohol treatment ...read more
2002: BA Philosophy; Oswego State University
2013: Postdoctoral Fellowship in Behavioral Pharmacology; Johns Hopkins University School of Medicine
I have focused primarily on the treatment of opioid use disorder using human subjects. I have worked on more than 10 randomized clinical trial evaluations of treatments for patients with opioid use disorder, and have contributed to research regarding medication development for alcohol use disorder and cigarette smoking. I am currently pursing several lines of research regarding methods to enhance opioid treatment outcomes, to improve prevention of opioid overdose, to understand mechanisms underlying the development of opioid use disorder, to reduce concurrent problems among patients with opioid use disorder, and to develop tools for sensitively measuring overdose risk and noninjection drug use behavior with an emphasis on reducing HIV and HCV risk behaviors. Finally, I also have training in the use of incentives (contingency management) to modify behaviors.
More generally, I have expertise in human laboratory based studies of behavioral pharmacological techniques, clinical trial management and development, including FDA Good Clinical Practice procedures and guidelines, and secondary analyses of research projects with an emphasis on evaluating clinically-relevant outcomes.
opioid; opiate; outcome measures; alcohol, overdose; smoking; incentive
Dunn, K.E., Sigmon, S.C. Thomas, C.S., Heil, S.H., & Higgins, S.T. Voucher-based contingent reinforcement of smoking abstinence among methadone-maintained patients: A pilot study. Journal of Applied Behavior Analysis. 2008. Vol. 41 (4), pp 527-538. PMCID: PMC2606604
Dunn, K.E., Sigmon, S.C., Reimann, E.R., Badger, G.J., Heil, S.H., & Higgins, S.T. A contingency-management intervention to promoteinitialsmoking cessation among opioid-maintained patients. Experimental and Clinical Psychopharmacology. 2010. Vol. 18 (1), pp 37-50. PMCID: PMC3131670
Dunn, K.E., Sigmon, S.C., Strain, E., Heil, S.H., & Higgins, S.T. The association between outpatient buprenorphine detoxification duration and clinical treatment outcomes: A review. Drug and Alcohol Dependence. 2011. Vol. 119 (1-2), pp 1-9. PMCID: PMC3205338.
Dunn, K.E., Saulsgiver, K.A., Patrick, M.E., Heil, S.H., Higgins, S.T., & Sigmon, S.C. Characterizing and Improving HIV and Hepatitis Knowledge Among Primary Prescription Opioid Abusers. Drug and Alcohol Dependence. 2013. Vol. 133 (2), pp 625-632. PMCID: PMC3824383
Sigmon, S.C., Dunn, K.E., Saulsgiver, K., Patrick, M., Badger, G.J., Heil, S.H., Brooklyn, J.R., & Higgins, S.T. Randomized, double-blind parametric evaluation of buprenorphine taper for the treatment of prescription opioid dependence. JAMA Psychiatry. 2013. Vol. 70 (12), pp 1347-1354. PMCID: PMC4131728
Dunn, K.E., Saulsgiver, K.A., Miller, M.E., Nuzzo, P.A., & Sigmon, S.C. (2015). Characterizing opioid withdrawal during double-blind buprenorphine detoxification. Drug and Alcohol Dependence, Vol. 151, pp 47-55.
Dunn, K.E., Finan, P., Tompkins, D.A., Fingerhood, M., & Strain, E.C. (2015). Characterizing pain and associated coping strategies in methadone and buprenorphine-maintained patients. Drug and Alcohol Dependence, Vol. 157, pp 143-149.
Science Student Council Behavioral Neuroscience Representative
Member Underrepresented Minorities Committee
{line break}
Early Career Representative to the Executive Committee
Division Newsletter Editor
Division Secretary
Program Chair
Early Career Psychologist Representative to Advocacy and Public Policy Committee
Member Program Committee